Welcome to the forefront of targeted drug delivery. At Creative Biolabs, we leverage decades of expertise in bioconjugation and nanomedicine to offer a comprehensive portfolio of Targeted Lipid Nanoparticle (LNP) products. These advanced delivery systems are engineered to overcome the limitations of conventional therapeutics, providing unprecedented precision, efficacy, and safety in targeting specific cells and tissues.
Lipid Nanoparticles (LNPs) have revolutionized the field of drug delivery, most notably in their role as the enabling technology for mRNA vaccines. LNPs are nanoscale spherical vesicles composed of ionizable lipids, structural lipids, cholesterol, and PEGylated lipids. They encapsulate and protect fragile therapeutic payloads, such as nucleic acids (mRNA, siRNA, DNA) or small molecules, facilitating their cellular uptake and endosomal escape.
Targeted LNPs elevate this technology by incorporating specific targeting ligands onto their surface. These ligands—which can be antibodies, peptides, aptamers, or small molecules—recognize and bind to distinct receptors overexpressed on the surface of target cells (e.g., tumor cells, specific immune cells, or hepatocytes). This active targeting mechanism ensures that the therapeutic payload is delivered precisely to the intended site of action, minimizing systemic toxicity and maximizing therapeutic impact.
Fig.1 Surface-Modified Lipid Nanoparticles for Targeted Delivery.
Our targeted LNP portfolio is categorized based on the specific surface modification strategy, allowing you to select the optimal platform for your research or development needs.
| Targeting Strategy | Mechanism of Action | Key Advantages |
|---|---|---|
| Antibody-Modified LNPs (Immuno-LNPs) | Monoclonal antibodies or antibody fragments (scFv, Fab) are conjugated to the LNP surface, offering high affinity and specificity for corresponding cellular antigens. | Exceptional targeting precision; ideal for complex antigens; high stability; well-established conjugation chemistries. |
| Peptide-Modified LNPs | Short targeting peptides are utilized to bind specific cellular receptors (e.g., integrins, transferrin receptors). | Smaller ligand size minimizes steric hindrance; lower immunogenicity; cost-effective synthesis; tunable binding affinity. |
| Small Molecule-Modified LNPs | Ligands such as folate, carbohydrates (e.g., GalNAc), or specific vitamins are used to target receptors highly expressed on certain tissues (e.g., liver, activated macrophages). | Excellent tissue penetration; low manufacturing cost; highly defined structures; proven clinical efficacy (e.g., GalNAc for hepatic delivery). |
Targeted LNPs are driving innovation across a broad spectrum of biomedical applications:
As your dedicated partner in nanomedicine development, Creative Biolabs offers distinct advantages:
Beyond our extensive catalog of off-the-shelf formulations, our capabilities extend to fully bespoke LNP solutions. We provide advanced custom conjugation services, enabling the precise modification of LNPs with your specific targeting ligands, including specialized antibodies, unique peptides, and small molecules. Furthermore, our expert team can seamlessly engineer and manufacture custom LNPs conjugated with your exact desired clone, ensuring optimal targeting and experimental continuity.
Creative Biolabs is more than a product supplier; we are your strategic development partner. To accelerate your research from concept to preclinical validation, we offer a comprehensive suite of customized nanomedicine services.
Online Inquiry